KGOU

Nomin Ujiyediin

KGOU Digital News Editor

Nomin Ujiyediin is a recent alum of the Graduate School of Journalism at the City University of New York and a graduate of Rutgers University.  She has worked at NPR’s Latino USA and WNYC in Manhattan.  When she’s not working, she’s often at the gym, behind the lens of a camera or at the movie theater.  You can follow her on Twitter and Instagram @NominUJ.

Ways to Connect

Sue Ogrocki / AP Photo

A state senator under investigation for unreported campaign donations has resigned.

Oklahoma State Senator Kyle Loveless of District 45 in central Oklahoma submitted a letter of resignation on Thursday morning.

Oklahoma Attorney General's Office

Oklahoma Attorney General Mike Hunter announced the formation of a state task force to combat opioid addiction on Wednesday.  

The Oklahoma Commission on Opioid Abuse will consist of nine members, including lawmakers, law enforcement, a dentist, a pharmacist, a nurse and a doctor. It will consider policy changes to prevent, treat and intervene in opioid addiction.

Oklahoma County District Attorney David Prater speaks to the Board of County Commissioners on Nov. 2.
Kate Carlton Greer / KGOU

The Oklahoma County district attorney has found no probable cause to charge a police officer responsible for the February shooting death of a man in Bethany.

U.S. Sen. James Lankford, R-Okla., talks to supporters during the Republican watch party in Oklahoma City, Tuesday, Nov. 8, 2016.
J. Pat Carter / AP

The U.S. Senate investigation into Russian interference in the 2016 presidential election is moving steadily, despite reports to the contrary, said Oklahoma Senator James Lankford in an interview with NPR's Rachel Martin on Tuesday morning.

 

RambergMediaImages / Flickr Creative Commons

The Cherokee Nation is seeking restitution for a drug abuse epidemic that has disproportionately affected members of its tribe.

The nation filed a lawsuit against major pharmaceutical companies and pharmacy retailers in tribal court on Thursday, alleging that these companies have unjustly profited off of selling medically unnecessary amounts of prescription opioids.

Pages